GlassScriptPhysician profile
Erin M Jigarjian
NPI 1942033287
$756.22
in general payments reported to CMS, 2019-2025
17 companies · $651 in 2025
The $651 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $105 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $158.59 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $103.06 | 2025 | Zepbound, Mounjaro, Kisunla |
| Merz Pharmaceuticals, LLC | $81.68 | 2024 | Inbrija |
| Abbvie INC. | $80.28 | 2025 | |
| Abiomed | $41.96 | 2025 | |
| Glaxosmithkline, LLC. | $33.20 | 2025 | Bexsero, Penmenvy |
| Seqirus USA INC | $28.51 | 2025 | Flucelvax, Fluad |
| Microtransponder, INC. | $28.50 | 2025 | |
| Alnylam Pharmaceuticals INC. | $28.25 | 2025 | Amvuttra |
| Alk-Abello, INC | $27.32 | 2025 | Neffy |
| Si-Bone, INC. | $25.08 | 2025 | |
| Astellas Pharma US INC | $24.80 | 2025 | Veozah |
| Exact Sciences Corporation | $22.65 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $20.33 | 2025 | Airsupra |
| Novartis Pharmaceuticals Corporation | $19.97 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $18.49 | 2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $13.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Jigarjian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.